Computer Monitor vs Augmented Reality 3MDR for PTSD PTSD: A Randomized Controlled Trial
Computer Monitor Versus Augmented Reality: Expanding 3MDR Therapy for PTSD
Uniformed Services University of the Health Sciences
60 participants
Apr 30, 2023
INTERVENTIONAL
Conditions
Summary
This is a prospective randomized controlled trial comparing two ways of delivering Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) therapy for posttraumatic stress disorder (PTSD). The study seeks 60 volunteers who have PTSD and are eligible for care in the Department of Defense healthcare system. There will be 10-14 therapy sessions that are 60-90 minutes long, about once a week, and symptoms will be assessed before and after the therapy as well as 3 and 6 months after completing therapy. 3MDR asks you to choose pictures and music that are integrated into a virtual reality environment. You will be walking on a treadmill throughout each therapy session, while the therapist stands next to the treadmill and asks you questions about the pictures you chose.
Eligibility
Inclusion Criteria3
- Service member, veteran, retiree, or DEERS-eligible dependent, male or female, at least 18 years or older
- Diagnosis of PTSD, as confirmed by the CAPS-5
- Able to ambulate with contact guard assistance or less, and walk unassisted on a treadmill, at a normal pace, for up to 90 minutes continuously
Exclusion Criteria3
- History of epilepsy or a seizure disorder, other than febrile seizures that occurred during childhood and have not recurred since
- History of a psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation
- Use of benzodiazepines on a regular basis within the previous 30 days
Interventions
"Walk and talk" therapy, walking on a treadmill while talking with a therapist about self-chosen pictures representative of one's trauma; 3MDR also includes some features of virtual reality exposure therapy (VRET) and Eye Movement Desensitization and Reprocessing (EMDR) therapy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05244564